Falasca compared 26 prostate adenocarcinoma and 12 normal specimens by immunohistochemistry and observed that AMBRA1 was highly expressed in prostate cancer (Falasca et al., 2015). This evidence concerns the gene AMBRA1 and Familial prostate cancer.